These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8396857)

  • 1. Interobserver reproducibility.
    Lobert PF
    Am J Surg Pathol; 1993 Oct; 17(10):1071-2. PubMed ID: 8396857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Borderline" breast lesions.
    Am J Surg Pathol; 1991 Nov; 15(11):1100-8. PubMed ID: 1656804
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of pathology in prognosis and management of breast cancer.
    Rilke F; Andreola S; Carbone A; Clemente C; Pilotti S
    Semin Oncol; 1978 Dec; 5(4):360-72. PubMed ID: 216114
    [No Abstract]   [Full Text] [Related]  

  • 7. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?
    Ellis IO; Pinder SE; Lee AH; Elston CW
    Semin Diagn Pathol; 1999 Aug; 16(3):202-8. PubMed ID: 10490197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology of high-risk breast lesions and ductal carcinoma in situ.
    Sewell CW
    Radiol Clin North Am; 2004 Sep; 42(5):821-30, v. PubMed ID: 15337418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The concept of carcinoma in situ].
    Andersen JA; Schiødt T
    Ugeskr Laeger; 1980 Mar; 142(14):867-9. PubMed ID: 6250258
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W
    Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?
    Tan PH; Ho BC; Selvarajan S; Yap WM; Hanby A
    J Clin Pathol; 2005 Jul; 58(7):705-9. PubMed ID: 15976336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anatomo-pathologic considerations on the subject of minimal carcinoma of the breast].
    Zampi G; Bianchi S; Amorosi A
    Minerva Chir; 1989 Feb; 44(3):419-21. PubMed ID: 2541375
    [No Abstract]   [Full Text] [Related]  

  • 13. [In situ breast carcinoma developing in a fibroadenoma. Apropos of 4 case reports].
    Travade A; Dauplat J; Peffault de Latour M; Lemery S; Lafaye C
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(5):597-600. PubMed ID: 2999214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperplastic lesions of the human breast: scanning electron microscopy and a review of current knowledge.
    Halter SA; Holt DH; Page DL
    Scan Electron Microsc; 1981; (Pt 3):11-21. PubMed ID: 6276966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).
    Kluttig A; Trocchi P; Heinig A; Holzhausen HJ; Taege C; Hauptmann S; Boecker W; Decker T; Loening T; Schmidt-Pokrzywniak A; Thomssen C; Lantzsch T; Buchmann J; Stang A
    BMC Cancer; 2007 Jun; 7():100. PubMed ID: 17570833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Definition and malignancy of carcinoma in situ of the mammary gland].
    Bässler R
    Verh Dtsch Ges Pathol; 1975; 59():497. PubMed ID: 175609
    [No Abstract]   [Full Text] [Related]  

  • 17. Ductal carcinoma in situ (intraductal carcinoma) of the breast.
    Schnitt SJ; Silen W; Sadowsky NL; Connolly JL; Harris JR
    N Engl J Med; 1988 Apr; 318(14):898-903. PubMed ID: 2832757
    [No Abstract]   [Full Text] [Related]  

  • 18. Sampling grossly benign breast biopsy specimens.
    Lancet; 1989 Aug; 2(8660):425-6. PubMed ID: 2569604
    [No Abstract]   [Full Text] [Related]  

  • 19. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M; Bachmann FF
    Med Welt; 1982 Jul; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
    Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
    Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.